How are FBRX's technical signals calculated?

Scanance computes FBRX's technicals daily after market close from end-of-day OHLCV data. MA150 and MA200 are simple moving averages. RSI uses Wilder's 14-period smoothing. MACD uses 12/26/9 exponential moving averages. Volume ratio compares current volume to the 20-day average.

Scanance does not provide investment advice. The technical readouts on this page are pattern matches against deterministic indicator rules. They are not buy or sell recommendations. Always do your own research and consider consulting a licensed financial professional before making any trade.

FB

Forte Biosciences, Inc.

FBRXHealthcareNASDAQ

Biotechnology · Last scanned Jul 18, 2026

PriceMA150MA200

Loading chart…

End-of-day data · ScananceOpen live chart on TradingView ↗

Indicator snapshot · Today

Premium

Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →

About Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Links

More Healthcare stocks

AAgilent Technologies, Inc.
AAPGAAPG
ABBVAbbVie Inc.
ABCLAbCellera Biologics Inc.
ABEOAbeona Therapeutics Inc.
ABSIAbsci Corporation
ABTAbbott Laboratories
ABUSArbutus Biopharma Corporation
ABVXABIVAX Société Anonyme
ACADACADIA Pharmaceuticals Inc.
ACHCAcadia Healthcare Company, Inc.
ACHVAchieve Life Sciences, Inc.
ACRSAclaris Therapeutics, Inc.
ADAGAdagene Inc.

Browse all stocks →

Forte Biosciences, Inc.

News & analytics is part of Premium.

Technical readouts are part of Premium.